1Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
2Department of Medicine, McGill University, Montreal, QC, Canada
3Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, ON, Canada
4Department of Medicine, University of Ottawa, Ottawa, ON, Canada
5Medical Council of Canada, Ottawa, ON, Canada
© 2019, Korea Health Personnel Licensing Examination Institute
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Authors’ contributions
Conceptualization: LM, CBL, MM, KK, DP. Data curation: DP. Formal analysis: DP, MM. Funding acquisition: KK. Methodology: LM, CBL, DP. Project administration: KK. Visualization: None. Writing–original draft: LM. Writing–review & editing: LM, CBL, MM, KK, DP.
Conflict of interest
Dr. Khamisa is a speaker for Amgen and Novartis Canada. The authors alone are responsible for the content and writing of this article. No potential conflict of interest relevant to this article was reported.
Funding
This study was funded by a grant from the Ottawa Blood Diseases Centre (OHCO 973 107 000), the Ottawa Hospital. The funding source had no role in data collection, analysis, or the preparation of this manuscript.
Variable | Mean M2 OSCE score±SD | t-value (df) | P-value |
---|---|---|---|
2016 M3 MOSCE | 1.500 (161) | 0.136 | |
Participants (n=43) | 78.5±3.7a) | ||
Non-participants (n=120) | 77.4±4.1a) | ||
2017 M3 MOSCE | 1.174 (161) | 0.242 | |
Participants (n=45) | 75.4±4.8b) | ||
Non-participants (n=118) | 74.5±4.1b) |
Variable | Mean second-year OSCE score±SD | t-value (df) | P-value |
---|---|---|---|
2016 Third-year MOSCE | 1.500 (161) | 0.136 | |
Participants (n=43) | 78.5±3.7a) | ||
Non-participants (n=120) | 77.4±4.1a) | ||
2017 Third-year MOSCE | 1.174 (161) | 0.242 | |
Participants (n=45) | 75.4±4.8b) | ||
Non-participants (n=118) | 74.5±4.1b) |
The independent-samples t-test was used, and 2-tailed P-values were calculated. For the 2016 third-year OSCE (n=172), the median was 65.5 (mean=65.1) and for the 2017 third-year OSCE (n=160), the median was 64.8 (mean=64.9). Using a median split, students were grouped as either high- or low-performing. The chi-square test for independence was performed and no relationship was found between performance (high or low) on the OSCE and participation in the MOSCE as either an examinee or standardized patient (see Tables 2–4).
OSCE, objective structural clinical examination; MOSCE, mock OSCE; SD, standard deviation; df, degrees of freedom.
a) Second-year OSCE score 2015.
b) Second-year OSCE score 2016.
Participation as mock OSCE 2016 examinee |
Third-year OSCE 2016 |
Total | |
---|---|---|---|
Low performers | High performers | ||
Yes | 20 | 26 | 46 |
No | 58 | 57 | 115 |
Total | 78 | 83 | 161 |
Participation as mock OSCE 2017 examinee |
Third-year OSCE 2017 |
Total | |
---|---|---|---|
Low performers | High performers | ||
Yes | 22 | 22 | 44 |
No | 54 | 57 | 111 |
Total | 76 | 79 | 155 |
Participation in mock OSCE 2017 as SP | Second-year OSCE 2017 | Total | |
---|---|---|---|
Low performers | High performers | ||
Yes | 10 | 5 | 15 |
No | 66 | 80 | 146 |
Total | 76 | 85 | 161 |
χ2 = (1, N=161), P=0.113. The correlation between 2016 mock OSCE scores and subsequent scores on a third-year OSCE were high (r=0.490, P=0.001). Similarly, the 2017 mock OSCE and subsequent third-year OSCE scores showed a high correlation (r=0.619, P<0.001). However, the correlation between the second-year and third-year OSCEs was also high (r=0.560, P<0.001; r=0.510, P<0.001).
OSCE, objective structured clinical examination; SP, standardized patient.
Variable | Mean M2 OSCE score±SD | t-value (df) | P-value |
---|---|---|---|
2016 M3 MOSCE | 1.500 (161) | 0.136 | |
Participants (n=43) | 78.5±3.7 |
||
Non-participants (n=120) | 77.4±4.1 |
||
2017 M3 MOSCE | 1.174 (161) | 0.242 | |
Participants (n=45) | 75.4±4.8 |
||
Non-participants (n=118) | 74.5±4.1 |
Variable | Mean second-year OSCE score±SD | t-value (df) | P-value |
---|---|---|---|
2016 Third-year MOSCE | 1.500 (161) | 0.136 | |
Participants (n=43) | 78.5±3.7 |
||
Non-participants (n=120) | 77.4±4.1 |
||
2017 Third-year MOSCE | 1.174 (161) | 0.242 | |
Participants (n=45) | 75.4±4.8 |
||
Non-participants (n=118) | 74.5±4.1 |
Participation as mock OSCE 2016 examinee | Third-year OSCE 2016 |
Total | |
---|---|---|---|
Low performers | High performers | ||
Yes | 20 | 26 | 46 |
No | 58 | 57 | 115 |
Total | 78 | 83 | 161 |
Participation as mock OSCE 2017 examinee | Third-year OSCE 2017 |
Total | |
---|---|---|---|
Low performers | High performers | ||
Yes | 22 | 22 | 44 |
No | 54 | 57 | 111 |
Total | 76 | 79 | 155 |
Participation in mock OSCE 2017 as SP | Second-year OSCE 2017 | Total | |
---|---|---|---|
Low performers | High performers | ||
Yes | 10 | 5 | 15 |
No | 66 | 80 | 146 |
Total | 76 | 85 | 161 |
The independent-samples t-test was used, and 2-tailed P-values were calculated. OSCE, objective structural clinical examination; MOSCE, mock OSCE; SD, standard deviation; df, degrees of freedom. M2 OSCE score 2015. M2 OSCE score 2016.
The independent-samples t-test was used, and 2-tailed P-values were calculated. For the 2016 third-year OSCE (n=172), the median was 65.5 (mean=65.1) and for the 2017 third-year OSCE (n=160), the median was 64.8 (mean=64.9). Using a median split, students were grouped as either high- or low-performing. The chi-square test for independence was performed and no relationship was found between performance (high or low) on the OSCE and participation in the MOSCE as either an examinee or standardized patient (see Tables 2–4). OSCE, objective structural clinical examination; MOSCE, mock OSCE; SD, standard deviation; df, degrees of freedom. Second-year OSCE score 2015. Second-year OSCE score 2016.
χ2 (1, N=161)=0.637, P=0.425. OSCE, objective structured clinical examination.
χ2= (1, N=155), P=0.879. OSCE, objective structured clinical examination.
χ2 = (1, N=161), P=0.113. The correlation between 2016 mock OSCE scores and subsequent scores on a third-year OSCE were high (r=0.490, P=0.001). Similarly, the 2017 mock OSCE and subsequent third-year OSCE scores showed a high correlation (r=0.619, P<0.001). However, the correlation between the second-year and third-year OSCEs was also high (r=0.560, P<0.001; r=0.510, P<0.001). OSCE, objective structured clinical examination; SP, standardized patient.